Similar articles

• Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.

  Fabrega AJ, Corwin CL, Hunsicker L. Fabrega AJ, et al. Transplant Proc. 1998 Jun;30(4):1562-3. doi: 10.1016/s0041-1345(98)00358-3. Transplant Proc. 1998. PMID: 9636634 No abstract available.
• Evaluation of various immunosuppressive regimes in second renal transplants.

  Toronyi E, Remport A, Járay J, Máthé Z, Borka P, Perner F. Toronyi E, et al. Transplant Proc. 2001 May;33(3):2315-6. doi: 10.1016/s0041-1345(01)02005-x. Transplant Proc. 2001. PMID: 11377543 No abstract available.
• Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.

  Bush WW. Bush WW. AACN Clin Issues. 1999 May;10(2):253-69; quiz 304-6. doi: 10.1097/00044067-199905000-00011. AACN Clin Issues. 1999. PMID: 10578712 Review.
• Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.

  Woodle ES, Thistlethwaite JR, Haas M, Josephson MA, Newell KA, Bruce DS, Millis JM, Piper JB, Charette JI. Woodle ES, et al. Transplant Proc. 1996 Apr;28(2):998-9. Transplant Proc. 1996. PMID: 8623495 Clinical Trial. No abstract available.
• Current status of immunosuppressive agents for solid organ transplantation in children.

  Coelho T, Tredger M, Dhawan A. Coelho T, et al. Pediatr Transplant. 2012 Mar;16(2):106-22. doi: 10.1111/j.1399-3046.2012.01644.x. Pediatr Transplant. 2012. PMID: 22360399 Review.